[Preventive effect of behavioral therapy plus flunarizine in children with migraine]

Yan-Zhao Chen1, Ning Li, Ke-Ying Zhou

  • 1Department of Pediatrics, Shenzhen People's Hospital, Second Clinical Medical College of Jinan University, Shenzhen, Guangdong 518020, China. zhoukeying@163.com.

Insights

Behavioral therapy combined with flunarizine effectively reduced migraine symptoms in children. This combination therapy showed superior clinical efficacy compared to flunarizine alone for pediatric migraine prevention.

Area of Science:

  • Pediatric neurology
  • Clinical pharmacology

Context:

  • Migraine is a common neurological disorder in children, significantly impacting their quality of life.
  • Current treatment strategies for pediatric migraine often involve pharmacological and non-pharmacological approaches.

Purpose:

  • To evaluate the preventive efficacy of behavioral therapy combined with flunarizine in pediatric migraine patients.
  • To compare the effectiveness of combination therapy versus flunarizine monotherapy.

Summary:

  • A randomized controlled trial involving 90 pediatric migraine patients compared behavioral therapy plus flunarizine against flunarizine alone over 3 months.
  • The combination therapy group showed statistically significant improvements in the Pediatric Migraine Disability Assessment Score (PedMIDAS) and Bussone headache index compared to the control group.

Impact:

  • Behavioral therapy plus flunarizine demonstrates enhanced clinical efficacy for preventing migraine in children.
  • This combined therapeutic approach offers a promising strategy for managing pediatric migraine.
  • Findings support the integration of behavioral interventions into pharmacological treatment plans for children with migraine.
Abstract